1. A Pharmacokinetic Bioequivalence Study of Fremanezumab Administered Subcutaneously Using an Autoinjector and a Prefilled Syringe. Issue 9 (7th January 2021) Authors: Cherniakov, Irina; Cohen‐Barak, Orit; Tiver, Ryan; Gillespie, Michael; Kessler, Yoel; Gutierrez, Maria; Rasamoelisolo, Michele; Li, Shawn; Shen, Honglue; Hallak, Hussein; Loupe, Pippa S.; Smith, Michael; Rabinovich‐Guilatt, Laura; Spiegelstein, Ofer Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 9(2021) Page Start: 1018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration‐QTc Analysis. Issue 1 (13th September 2022) Authors: Schneider, Frank; Darpo, Borje; Loupe, Pippa S.; Xue, Hongqi; Knebel, Helena; Gutierrez, Maria; Gordon, Mark Forrest; Rabinovich‐Guilatt, Laura Journal: Clinical pharmacology in drug development Issue: Volume 12:Issue 1(2023) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fremanezumab for preventive treatment of migraine: Functional status on headache-free days. (18th September 2018) Authors: VanderPluym, Juliana; Dodick, David W.; Lipton, Richard B.; Ma, Yuju; Loupe, Pippa S.; Bigal, Marcelo E. Journal: Neurology Issue: Volume 91:Number 12(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect. Issue 6 (10th October 2020) Authors: Schneider, Frank; Stamler, David; Bradbury, Margaret; Loupe, Pippa S.; Hellriegel, Edward; Cox, Donna S.; Savola, Juha‐Matti; Gordon, Mark Forrest; Rabinovich‐Guilatt, Laura Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 6(2021) Page Start: 647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects. (9th August 2018) Authors: Schneider, Frank; Erisson, Lavi; Beygi, Hooman; Bradbury, Margaret; Cohen‐Barak, Orit; Grachev, Igor D.; Guzy, Serge; Loupe, Pippa S.; Levi, Micha; McDonald, Mirna; Savola, Juha‐Matti; Papapetropoulos, Spyros; Tracewell, William G.; Velinova, Maria; Spiegelstein, Ofer Journal: British journal of clinical pharmacology Issue: Volume 84:Number 10(2018) Page Start: 2422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence. (1st September 2016) Authors: Gilgun-Sherki, Yossi; Eliaz, Rom E.; McCann, David J.; Loupe, Pippa S.; Eyal, Eli; Blatt, Kathleen; Cohen-Barak, Orit; Hallak, Hussein; Chiang, Nora; Gyaw, Shwe Journal: Drug and alcohol dependence Issue: Volume 166(2016) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence. (1st September 2016) Authors: Gilgun-Sherki, Yossi; Eliaz, Rom E.; McCann, David J.; Loupe, Pippa S.; Eyal, Eli; Blatt, Kathleen; Cohen-Barak, Orit; Hallak, Hussein; Chiang, Nora; Gyaw, Shwe Journal: Drug and alcohol dependence Issue: Volume 166(2016) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points. (5th July 2016) Authors: Bigal, Marcelo E.; Dodick, David W.; Krymchantowski, Abouch V.; VanderPluym, Juliana H.; Tepper, Stewart J.; Aycardi, Ernesto; Loupe, Pippa S.; Ma, Yuju; Goadsby, Peter J. Journal: Neurology Issue: Volume 87:Number 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post‐Hoc Analyses on the First 3 Weeks of Treatment. Issue 3 (18th November 2018) Authors: Silberstein, Stephen D.; Rapoport, Alan M.; Loupe, Pippa S.; Aycardi, Ernesto; McDonald, Mirna; Yang, Ronghua; Bigal, Marcelo E. Journal: Headache Issue: Volume 59:Issue 3(2019) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The Effect of CYP3A Induction and Inhibition on the Pharmacokinetics of Laquinimod, a Novel Neuroimmunomodulator. Issue 8 (1st April 2020) Authors: Elgart, Anna; Greenblatt, David J.; Loupe, Pippa S.; Zur, Arik A.; Weiss, Sivan; Mimrod, Dorit; Spiegelstein, Ofer Journal: Clinical pharmacology in drug development Issue: Volume 9:Issue 8(2020) Page Start: 1015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗